A single mid-follicular dose of CDB-2914, a new antiprogestin, inhibits folliculogenesis and endometrial differentiation in normally cycling women.
about
Progesterone receptor modulator for emergency contraception: a randomized controlled trialEndometrial effects of a single early luteal dose of the selective progesterone receptor modulator CDB-2914CDB-2914 for uterine leiomyomata treatment: a randomized controlled trialMechanism of Action of Ulipristal Acetate for Emergency Contraception: A Systematic ReviewVaginal ring delivery of selective progesterone receptor modulators for contraceptionSelective progesterone receptor modulators: an updateImmediate pre-ovulatory administration of 30 mg ulipristal acetate significantly delays follicular ruptureControl of oocyte release by progesterone receptor-regulated gene expression.Nowadays which emergency contraception? Comparison between past and present: latest news in terms of clinical efficacy, side effects and contraindications.Emergency contraception: potential role of ulipristal acetateEffects of ulipristal acetate on human embryo attachment and endometrial cell gene expression in an in vitro co-culture system.Efficacy of ulipristal acetate for emergency contraception and its effect on the subsequent bleeding pattern when administered before or after ovulation.New developments in contraceptive drugs for use by women.Stem cells, progenitor cells, and lineage decisions in the ovary.Effects of a novel estrogen-free, progesterone receptor modulator contraceptive vaginal ring on inhibition of ovulation, bleeding patterns and endometrium in normal women.Ulipristal blocks ovulation by inhibiting progesterone receptor-dependent pathways intrinsic to the ovary.Ulipristal acetate: a review of its use in emergency contraception.Ulipristal acetate: a new emergency contraceptive.Ulipristal acetate as an emergency contraceptive agent.Ulipristal acetate: critical review about endometrial and ovulatory effects in emergency contraception.Pharmacokinetic and pharmacodynamic drug interactions between antiretrovirals and oral contraceptives.A prospective, randomized, pharmacodynamic study of quick-starting a desogestrel progestin-only pill following ulipristal acetate for emergency contraception.Ulipristal acetate - safety and pharmacokinetics following multiple doses of 10-50 mg per day.Pharmacokinetic evaluation of ulipristal acetate for uterine leiomyoma treatment.Effect of ulipristal acetate and mifepristone at emergency contraception dose on the embryo-endometrial attachment using an in vitro human trophoblastic spheroid and endometrial cell co-culture model.Role of the community pharmacist in emergency contraception counseling and delivery in the United States: current trends and future prospects.Emergency Contraception
P2860
Q24597134-9E1929C3-3316-4362-BA15-6A436925A221Q24601691-508B52AE-0258-4998-BC4F-DAB241CA9186Q24655722-3FE09C74-C395-4C0A-9F84-28E092441D28Q26770436-61B91855-EB7E-44D2-84AB-3BF9149F34F9Q26864069-08CE173F-0E87-47CC-A66F-E940349DF06BQ28239255-345FBA46-90CF-45EB-9C98-20C0B200CBDAQ28287995-48E5D169-7C97-420F-B238-80A8DC9F2760Q33595244-A1C8C0C6-38D3-4B5A-B14D-DAC9F3C5CEB1Q34258667-ED08C330-CF6F-4B5E-BA0D-CAF7EC56AF96Q34272222-F33C3647-BD75-469F-A149-8F461A95F7A3Q34668355-48BBA932-4A63-4D12-A66E-1E0110C3C0EFQ34676784-896CF58A-8121-4E37-9939-A1976C46CD0EQ34841753-C0992F2C-BB7E-4CBA-85DA-FBDD162EEC9CQ35833271-91672D7E-8912-4762-9513-4A81E335C0BAQ36119750-A53785B8-01C4-4765-9C52-55EC89048CB9Q36912125-3566BAD6-DF58-4BB5-921D-834FF6651CE1Q37875065-1EA7FBF4-A114-4E69-9BBB-A778B2399773Q37960522-30A8CCE9-CCD9-411A-8E19-172E111B6F18Q38024429-DCAF784A-21FC-4698-9DCC-59A6C1F00E58Q38179825-47AE1B2F-C1BA-481E-A19F-D135165864A9Q38261574-9D45750B-ABF9-481D-8B2D-3253297339A2Q38592700-722F9712-7C82-4EFF-BCA3-8848C0D38427Q42712110-4C342903-4D60-4C20-8B3C-99F41125521AQ42717625-299798D5-FB82-48D9-9D6D-123BFA85766FQ47221830-3CEB5E30-3EE0-407D-8A56-CDEF860137E1Q47721143-C95108FF-0CBE-481D-947E-0C4A8F5211C9Q56051166-BD7B5523-38FD-4F10-8995-EAFE05309989
P2860
A single mid-follicular dose of CDB-2914, a new antiprogestin, inhibits folliculogenesis and endometrial differentiation in normally cycling women.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
A single mid-follicular dose o ...... ion in normally cycling women.
@en
A single mid-follicular dose o ...... ion in normally cycling women.
@nl
type
label
A single mid-follicular dose o ...... ion in normally cycling women.
@en
A single mid-follicular dose o ...... ion in normally cycling women.
@nl
prefLabel
A single mid-follicular dose o ...... ion in normally cycling women.
@en
A single mid-follicular dose o ...... ion in normally cycling women.
@nl
P2093
P356
P1433
P1476
A single mid-follicular dose o ...... ion in normally cycling women.
@en
P2093
Hajizadeh N
Stratton P
Sutherland D
P304
P356
10.1093/HUMREP/15.5.1092
P407
P577
2000-05-01T00:00:00Z